CTLA4 and Alzheimer disease: Both non-AD and AD mice showed that ear swelling at 24 h was enhanced (non-AD; p = 0.038, AD; p = 0.022) in the anti-CTLA-4 mAb group compared to the anti-IgG mAb group after the challenge.